What is the stock price of Eli Lilly and Company?

Written by Editorial Team | Last Updated: August 2026

Eli Lilly and Company is a major global pharmaceutical giant renowned for its extensive portfolio of medications, particularly in areas like diabetes care, oncology, immunology, and neuroscience, including highly sought-after treatments for weight management and metabolic health. As share prices shift continuously throughout the trading day driven by clinical trial results, regulatory approvals from agencies like the FDA, earnings announcements, and broader pharmaceutical sector trends, I do not have access to real-time financial market data. To view the exact live stock price for Eli Lilly and Company (trading under the ticker LLY on the New York Stock Exchange), please consult professional financial market tracking websites, stock market applications, or official investor relations resources.

Related FAQs

Peet's Coffee has faced consumer class action lawsuits and labeling disputes regarding product representations and food safety standards.

Coffee enthusiasts and culinary critics often debate whether Peet's Coffee offers superior quality compared to Starbucks, frequently noting that Peet's emphasizes darker, richer bean roasts, traditional hand-packed espresso shots, and bolder flavor p...

Starbucks (alongside mass-market consumer packaged brands like Folgers and Maxwell House sold in grocery stores) represents the leading coffee choice for American consumers.

Keurig Dr Pepper maintains a policy of engaging in the political process through lawful contributions to federal and state political parties, committees, and candidates.

JDE Peet's is a massive global coffee and tea consumer products giant that manages an extensive portfolio of world-renowned beverage brands and regional subsidiary companies.

Evaluating whether JD Sports stock represents a worthwhile purchase depends heavily on an investor's individual portfolio strategy, risk tolerance, and outlook on discretionary retail performance.

Evaluating whether Peet's Coffee maintains a more ethical operational profile than Starbucks involves reviewing their respective sustainable sourcing initiatives, third-party farm audits, and community development investments.

JDE Peet's N.V. trades on Euronext Amsterdam under the ticker symbol JDEP with shares valued around €31.70, while its sponsored American Depositary Receipts trade under the ticker JDEPY around $16.10 per share.

Pegasystems Inc. (Pega) possesses a strong and promising future anchored by its enterprise low-code application development platforms, customer relationship management software, and advanced artificial intelligence process automation tools.

JDE, operating as JDE Peet's, is a global coffee and tea giant headquartered in Amsterdam, Netherlands, formed through the combination of Jacobs Douwe Egberts and Peet's Coffee.

Peet's Coffee is not discontinued, remaining a highly popular specialty coffee roaster, retailer, and consumer brand with widespread distribution across thousands of grocery stores, retail channels, and dedicated coffeebar locations.

Peet's Coffee implements rigorous quality control standards and responsible sourcing guidelines, partnering with independent verification organizations like Enveritas to audit coffee farms for environmental sustainability, social standards, and agric...

JDE Peet's N.V., a massive global consumer goods and beverage enterprise housing world-famous coffee and tea brands such as Jacobs, Douwe Egberts, L'OR, and Peet's Coffee, has its global corporate headquarters located in Amsterdam, Netherlands.

Projecting the future trajectory of John Deere stock involves balancing long-term technological tailwinds—such as the expanding adoption of data-driven precision farming and automated fleet management—against short-term cyclical pressures in the farm...

Equity analysts express varying opinions regarding whether JD.

Wall Street analysts covering JD.com, Inc. (NASDAQ: JD) have established a consensus 12-month price target averaging between $39.57 and $40.12. Forecasts range from a low target of $27.00 up to a high estimate of roughly $54.42.